The Shirley Ryan AbilityLab, formerly the Rehabilitation Institute of Chicago, is a not-for-profit nationally ranked physical medicine and rehabilitation research hospital based in Chicago, Illinois.

During the past decade, Shirley Ryan AbilityLab conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 37 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 16 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shirley Ryan AbilityLab" #1 sponsor was "Shirley Ryan AbilityLab" with 107 trials, followed by "Northwestern University" with 7 trials sponsored, "Ipsen" with 6 trials sponsored, "Pfizer" with 5 trials sponsored and "Acorda Therapeutics" with 5 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shirley Ryan AbilityLab" #1 collaborator was "Shirley Ryan AbilityLab" with 23 trials as a collaborator, "Northwestern University" with 10 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 8 trials as a collaborator, "U.S. Department of Education" with 8 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 6 trials as a collaborator. Other collaborators include 122 different institutions and companies that were collaborators in the rest 111 trials.

According to Clinical.Site data, the most researched conditions in "Shirley Ryan AbilityLab" are "Stroke" (48 trials), "Spinal Cord Injuries" (21 trials), "Spinal Cord Injury" (19 trials), "Cerebral Palsy" (9 trials) and "Amputation" (6 trials). Many other conditions were trialed in "Shirley Ryan AbilityLab" in a lesser frequency.

Most popular intervention types in "Shirley Ryan AbilityLab" are "Device" (69 trials), "Other" (50 trials), "Drug" (32 trials), "Behavioral" (22 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "placebo" (6 trials), "Acute Intermittent Hypoxia" (4 trials), "Botulinum toxin type A" (4 trials) and "Acute Intermittent Hypoxia (AIH)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shirley Ryan AbilityLab" are 172 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 72 active trials in "Shirley Ryan AbilityLab". 2 are not yet recruiting, 52 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 82 completed trials in Shirley Ryan AbilityLab, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Shirley Ryan AbilityLab, 13 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 106 trials that are defined as “Not Applicable".

Shirley Ryan AbilityLab has several departments that took part in Clinical trials: "Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago" - 2 trials